BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 31054900)

  • 21. Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives.
    Majumder S; Shivaji UN; Kasturi R; Sigamani A; Ghosh S; Iacucci M
    World J Gastrointest Oncol; 2022 Mar; 14(3):547-567. PubMed ID: 35321275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer.
    Colombo G; Gelardi ELM; Balestrero FC; Moro M; Travelli C; Genazzani AA
    Front Pharmacol; 2021; 12():758320. PubMed ID: 34880756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease.
    Ocansey DKW; Pei B; Xu X; Zhang L; Olovo CV; Mao F
    J Transl Med; 2021 Jun; 19(1):254. PubMed ID: 34112196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CircRNAs as promising biomarkers of inflammatory bowel disease and its associated-colorectal cancer.
    Xu Y; Xu X; Ocansey DKW; Cao H; Qiu W; Tu Q; Mao F
    Am J Transl Res; 2021; 13(3):1580-1593. PubMed ID: 33841681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
    Yarla NS; Madka V; Pathuri G; Rao CV
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obacunone reduces inflammatory signalling and tumour occurrence in mice with chronic inflammation-induced colorectal cancer.
    Luo X; Yu Z; Yue B; Ren J; Zhang J; Mani S; Wang Z; Dou W
    Pharm Biol; 2020 Dec; 58(1):886-897. PubMed ID: 32878512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities.
    Neitzel C; Demuth P; Wittmann S; Fahrer J
    Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer.
    Muller M; Hansmannel F; Arnone D; Choukour M; Ndiaye NC; Kokten T; Houlgatte R; Peyrin-Biroulet L
    United European Gastroenterol J; 2020 Jul; 8(6):675-684. PubMed ID: 32268844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
    Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
    Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
    Yaeger R; Shah MA; Miller VA; Kelsen JR; Wang K; Heins ZJ; Ross JS; He Y; Sanford E; Yantiss RK; Balasubramanian S; Stephens PJ; Schultz N; Oren M; Tang L; Kelsen D
    Gastroenterology; 2016 Aug; 151(2):278-287.e6. PubMed ID: 27063727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
    Du L; Kim JJ; Shen J; Chen B; Dai N
    Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational profiling of colorectal cancers with microsatellite instability.
    Lin EI; Tseng LH; Gocke CD; Reil S; Le DT; Azad NS; Eshleman JR
    Oncotarget; 2015 Dec; 6(39):42334-44. PubMed ID: 26517354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers.
    Olaru AV; Cheng Y; Agarwal R; Yang J; David S; Abraham JM; Yu W; Kwon JH; Lazarev M; Brant SR; Marohn MR; Hutcheon DF; Harpaz N; Meltzer SJ; Mori Y
    Inflamm Bowel Dis; 2012 Apr; 18(4):641-8. PubMed ID: 21830278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular landscape of colitis-associated carcinogenesis.
    Saraggi D; Fassan M; Mescoli C; Scarpa M; Valeri N; Michielan A; D'Incá R; Rugge M
    Dig Liver Dis; 2017 Apr; 49(4):326-330. PubMed ID: 28089111
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.